Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)
Clinical trial NCT04668950 · COMPLETED
Trial details
- NCT number
- NCT04668950
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2021-09-28
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.